The Asia-Pacific Liquid Biopsy market is expected to increase at a CAGR of 31.23% in the forecast period of 2016-2021

“Asia-Pacific Liquid Biopsy Market" research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 31.23% to reach USD 482.37 million by 2021, from USD 123.94 million in 2016, which amounts to a cumulative growth of USD 358.43 million.

Liquid biopsy is the process of sampling and analysis of tumour circulating in the blood or pieces of DNA from tumour cells circulating in blood. It is also used to identify the working of treatment of cancer. Multiple sampling of blood helps the doctors to understand the kind of molecular changes in tumour.

Through liquid biopsy detection of diseases can be easily forecasted, gives a guide of treatment and to disclose the secrets of evolution of cancer cells. Researchers have high scope of learning from the biological detritus cast off by primary tumours and metastases. Internationally, most of the industrialized nations are spending a huge part of their GDP on healthcare necessities. The demand for liquid biopsy in the pharmaceuticals and biotechnology companies and research laboratories is enormous.

The report also presents detailed analysis of multitude of factors affecting the diagnostic imaging market bearing either positive or negative outcomes. Some of those factors are
• Increasing prevalence of cancerous diseases,
• Rise in cognizance for prompt diagnosis,
• Improving healthcare infrastructure in developing markets
• Stringent Government Regulations
• Lack of skilled professionals

Get free sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-liquid-biopsy-market-953/request-sample

For granular level understanding the Liquid Biopsy Market is segmented based on cancer type and sample type, diagnostic approach and end users, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Cancer Type the market is segmented as Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. Based on Sample type the market is also segmented as Blood, Urine, Plasma, Saliva, Cerebrospinal and Cancer. Based on diagnostic approach the market is further segmented as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end- users the market is furthermore segmented into the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users.

With India and China being the major economies which have unexplored customer base covered in the study the report also focuses on other regions like Japan, Australia, South Korea and Rest of Asia-Pacific. Asia- Pacific region is estimated to be fastest growing in terms of CAGR due to increasing competition among market players.

Some of the key players that operate in the Liquid Biopsy market include Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics and Myriad Genetics. Globally, North America holds the largest market share in Liquid Biopsy market. Europe holds the second largest share in liquid biopsy market.

The Asia- Pacific Liquid Biopsy market report offers wide-range of scope:

• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries

• Know more about key areas of industry growth via detailed Segment-level analysis on basis of cancer type and sample type, diagnostic approach, end users along with market size forecasts and y-o-y estimations

• Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics

• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & microenvironmental factors that affect the market demographics

• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview

• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options

Contact:
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Jubilee Gardens,
Hyderabad, India.

This release was published on openPR.